GlassScriptPhysician profile
Erin Salter
NPI 1851754287
$5,763.04
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.14 · 2022: $339 · 2023: $5,016 · 2024: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,822 · Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,822.14 |
| Food and Beverage | $583.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Davinci Xi |
| Medtronic, INC. | $1,198.20 | 2022-2024 | Interstim |
| Valencia Technologies Corporation | $835.36 | 2023 | Ecoin Device Kit |
| Boston Scientific Corporation | $365.46 | 2024 | |
| Allergan, INC. | $83.47 | 2022 | |
| Abbvie INC. | $79.30 | 2022-2023 | Botox |
| Janssen Biotech, INC. | $25.32 | 2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $22.12 | 2023 | |
| Merck Sharp & Dohme LLC | $21.20 | 2023 | Keytruda |
| Urogen Pharma, INC. | $20.48 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $18.14 | 2021 | |
| Sumitomo Pharma America, INC. | $17.37 | 2023 | Orgovyx |
| Smith+Nephew, INC. | $16.81 | 2022 | |
| Teleflex LLC | $15.98 | 2023 | Urolift |
| Axonics, INC. | $15.09 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $15.07 | 2023 | Provenge |
| Astellas Pharma US INC | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.